Search | OpenScholar

Search results

818 results found

Identification of motor and nonmotor wearing-off in Parkinson’s disease: Comparison of a patient questionnaire versus a clinician assessment. Mov Disord 2005;20: 726-733.

Publication: Journal Article

Stacy, M, A Bowron, M Guttman, R Hauser, K Hughes, JP Larsen, P LeWitt, et al. 2005. “Identification of Motor and Nonmotor Wearing-off in Parkinson’s Disease: Comparison of a Patient Questionnaire versus a Clinician Assessment. Mov Disord 2005;20: 726-733.”. Mov Disord.

Tegaserod (Zelnorm) for the treatment of constipation in Parkinson’s disease.

Publication: Journal Article

Sullivan, KL, JK Staffetti, RA Hauser, PB Dunne, and TA Zesiewicz. 2006. “Tegaserod (Zelnorm) for the Treatment of Constipation in Parkinson’s Disease.”. Movement Disorders.

Clinical trials aimed at detecting neuroprotection in Parkinson’s disease.

Publication: Journal Article

Hauser, RA, and T Zesiewicz. 2006. “Clinical Trials Aimed at Detecting Neuroprotection in Parkinson’s Disease.”. Neurology.

Use of nutritional supplements in Parkinson’s disease patients.

Publication: Journal Article

Wolfrath, SC, AR Borenstein, S Schwartz, RA Hauser, KL Sullivan, and TA Zesiewicz. 2006. “Use of Nutritional Supplements in Parkinson’s Disease Patients.”. Movement Disorders.

Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Arch Neurol 2006;63:1181-1184.

Publication: Journal Article

Graff-Radford, J, KD Foote, RL Rodriguez, HH Fernandez, RA Hauser, and . 2006. “Deep Brain Stimulation of the Internal Segment of the Globus Pallidus in Delayed Runaway Dyskinesia. Arch Neurol 2006;63:1181-1184.”. Arch Neurol.

Levodopa/carbidopa/entacapone for the treatment of Parkinson’s disease.

Publication: Journal Article

Samanta, J, and RA Hauser. 2006. “Levodopa/Carbidopa/Entacapone for the Treatment of Parkinson’s Disease.”. Aging Health.

Ropinirole therapy for Parkinson’s disease. Expert Review of Neurotherapeutics 2004;4:581-588.

Publication: Journal Article

Pahwa, R, K Lyons, and RA Hauser. 2004. “Ropinirole Therapy for Parkinson’s Disease. Expert Review of Neurotherapeutics 2004;4:581-588.”. Expert Review of Neurotherapeutics.

Future treatments for Parkinson’s disease. Neurol Clin 2004;22(Suppl 3):S149-166.

Publication: Journal Article

Hauser, RA, and K Lyons. 2004. “Future Treatments for Parkinson’s Disease. Neurol Clin 2004;22(Suppl 3):S149-166.”. Neurol Clin.

Management of essential tremor. Curr Neurol Neurosci Rep 2002;2:324-330.

Publication: Journal Article

Zesiewicz, TA, E Encarnacion, and RA Hauser. 2002. “Management of Essential Tremor. Curr Neurol Neurosci Rep 2002;2:324-330.”. Curr Neurol Neurosci Rep.

A controlled trial of rasagiline in early Parkinson Disease. Arch Neurol 2002;59:1937-1943.

Publication: Journal Article

Group, Parkinson Study. 2002. “A Controlled Trial of Rasagiline in Early Parkinson Disease. Arch Neurol 2002;59:1937-1943.”. Arch Neurol.